- Poster presentation
Kinetics of TREM-1 expression on canine neutrophils after in vitro and in vivo stimulation with microbial products
Critical Care volume 14, Article number: P35 (2010)
The triggering receptor expressed on myeloid cells-1 (TREM-1) is a recently discovered cell surface molecule expressed on neutrophils, mature monocytes, and macrophages . Activation of TREM-1 synergistically enhances proinflammatory cytokine production induced by toll-like receptor (TLR) stimulation . A soluble form of TREM-1 has shown promise as a sensitive and specific biomarker for sepsis in humans [3–5]. Expression and function of TREM-1 in the dog has yet to be characterized. We hypothesize that the expression of canine TREM-1 will be upregulated after stimulation with TLR agonists. We assessed TREM-1 expression on canine neutrophils after exposure to TLR agonists in vitro and in vivo after i.v. LPS administration. In vitro, expression of TREM-1 on neutrophils is significantly upregulated by stimulation with microbe-derived agonists against TLR2/6 (Pam2CSK4), TLR1/2 (Pam3CSK4), and TLR4/MD2 (ultrapure LPS and wildtype LPS) (paired t test, P < 0.05). The TLR5 agonist flagellin did not significantly upregulate TREM-1 expression at any time point. See Figure 1. In contrast, i.v. administration of LPS to dogs resulted in a significant decrease in both TREM-1 expression and the percentage of TREM-1-positive neutrophils from 6 hours through 12 hours post LPS administration. See Figure 2. The disparity between in vitro and in vivo effects of LPS suggest other factors, such as systemic and local cytokine production and neutrophil turnover, may influence expression and shedding of TREM-1 on canine neutrophils. We suggest that naturally occurring sepsis in the dog represents the ideal model for defining diagnostic biomarkers and discovering efficacious therapeutics for use in human sepsis.
Bouchon A, Dietrich J, Colonna M: Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol 2000, 164: 4991-4995.
Bouchon A, Facchetti F, Weigand MA, Colonna M: TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 2001, 410: 1103-1107. 10.1038/35074114
Gibot S, Kolopp-Sarda MN, Bene MC, et al.: Plasma level of a triggering receptor expressed on myeloid cells-1: its diagnostic accuracy in patients with suspected sepsis. Ann Intern Med 2004, 141: 9-15.
Gibot S, Cravoisy A, Levy B, et al.: Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med 2004, 350: 451-458. 10.1056/NEJMoa031544
Gibot S, Cravoisy A: Soluble form of the triggering receptor expressed on myeloid cells-1 as a marker of microbial infection. Clin Med Res 2004, 2: 181-187. 10.3121/cmr.2.3.181
This presentation was supported by Morris Animal Foundation and ICARE.
About this article
Cite this article
Li, J., Birkenheuer, A., Levy, M. et al. Kinetics of TREM-1 expression on canine neutrophils after in vitro and in vivo stimulation with microbial products. Crit Care 14, P35 (2010). https://doi.org/10.1186/cc9138
- Cytokine Production
- Surface Molecule
- Microbial Product
- Cell Surface Molecule
- Proinflammatory Cytokine Production